VRNA logo

Verona Pharma plc (VRNA) Cash from operations

annual CFO:

-$122.20M-$71.98M(-143.33%)
December 31, 2024

Summary

  • As of today (August 31, 2025), VRNA annual cash flow from operations is -$122.20 million, with the most recent change of -$71.98 million (-143.33%) on December 31, 2024.
  • During the last 3 years, VRNA annual CFO has fallen by -$88.95 million (-267.48%).
  • VRNA annual CFO is now -3594305.88% below its all-time high of $3400.00, reached on December 31, 2005.

Performance

VRNA Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

quarterly CFO:

$30.77M+$42.37M(+365.12%)
June 1, 2025

Summary

  • As of today (August 31, 2025), VRNA quarterly cash flow from operations is $30.77 million, with the most recent change of +$42.37 million (+365.12%) on June 1, 2025.
  • Over the past year, VRNA quarterly CFO has increased by +$47.52 million (+283.63%).
  • VRNA quarterly CFO is now at all-time high.

Performance

VRNA quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

TTM CFO:

-$72.37M+$47.52M(+39.64%)
June 1, 2025

Summary

  • As of today (August 31, 2025), VRNA TTM cash flow from operations is -$72.37 million, with the most recent change of +$47.52 million (+39.64%) on June 1, 2025.
  • Over the past year, VRNA TTM CFO has dropped by -$18.50 million (-34.33%).
  • VRNA TTM CFO is now -1541.74% below its all-time high of -$4.41 million, reached on March 31, 2017.

Performance

VRNA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VRNA Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-143.3%+283.6%-34.3%
3 y3 years-267.5%+258.6%-155.8%
5 y5 years-185.1%+1098.7%-108.3%

VRNA Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-267.5%at lowat high+148.8%-155.8%+40.8%
5 y5-year-267.5%at lowat high+148.8%-353.2%+40.8%
alltimeall time<-9999.0%at lowat high+148.8%-1541.7%+40.8%

VRNA Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$30.77M(-365.1%)
-$72.37M(-39.6%)
Mar 2025
-
-$11.61M(-59.2%)
-$119.89M(-1.9%)
Dec 2024
-$122.20M(+143.3%)
-$28.47M(-54.9%)
-$122.25M(+17.3%)
Sep 2024
-
-$63.07M(+276.4%)
-$104.21M(+93.4%)
Jun 2024
-
-$16.76M(+20.0%)
-$53.87M(-8.0%)
Mar 2024
-
-$13.97M(+34.0%)
-$58.55M(+16.1%)
Dec 2023
-$50.22M(-16.1%)
-$10.42M(-18.1%)
-$50.42M(+4.5%)
Sep 2023
-
-$12.73M(-40.6%)
-$48.23M(-9.4%)
Jun 2023
-
-$21.43M(+267.3%)
-$53.27M(+4.0%)
Mar 2023
-
-$5.83M(-29.2%)
-$51.23M(-14.4%)
Dec 2022
-$59.86M(+80.0%)
-$8.24M(-53.6%)
-$59.83M(-13.1%)
Sep 2022
-
-$17.76M(-8.4%)
-$68.87M(+143.5%)
Jun 2022
-
-$19.39M(+34.4%)
-$28.29M(-2.7%)
Mar 2022
-
-$14.43M(-16.5%)
-$29.06M(-12.6%)
Dec 2021
-$33.25M(-26.2%)
-$17.28M(-175.7%)
-$33.25M(+108.2%)
Sep 2021
-
$22.82M(-213.1%)
-$15.97M(-67.3%)
Jun 2021
-
-$20.17M(+8.3%)
-$48.86M(+53.8%)
Mar 2021
-
-$18.62M(+84.7%)
-$31.77M(-15.6%)
Dec 2020
-$45.08M(+5.2%)
-
-
Sep 2020
-
-$10.08M(+227.1%)
-$37.63M(+8.3%)
Jun 2020
-
-$3.08M(-76.7%)
-$34.74M(-17.6%)
Mar 2020
-
-$13.23M(+17.7%)
-$42.17M(+1.3%)
Dec 2019
-$42.87M
-$11.24M(+56.3%)
-$41.62M(+13.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$7.19M(-31.6%)
-$36.83M(+24.0%)
Jun 2019
-
-$10.51M(-17.1%)
-$29.70M(+9.1%)
Mar 2019
-
-$12.68M(+96.6%)
-$27.22M(+17.7%)
Dec 2018
-$22.98M(-17.8%)
-$6.45M(>+9900.0%)
-$23.13M(+0.5%)
Sep 2018
-
-$57.50K(-99.3%)
-$23.00M(-30.0%)
Jun 2018
-
-$8.03M(-6.5%)
-$32.85M(+5.9%)
Mar 2018
-
-$8.59M(+35.8%)
-$31.02M(+15.6%)
Dec 2017
-$27.97M(+305.8%)
-$6.33M(-36.1%)
-$26.84M(+30.8%)
Sep 2017
-
-$9.91M(+59.7%)
-$20.52M(+93.3%)
Jun 2017
-
-$6.20M(+40.7%)
-$10.61M(+140.7%)
Mar 2017
-
-$4.41M
-$4.41M
Dec 2016
-$6.89M(-26.8%)
-
-
Dec 2015
-$9.42M(+70.9%)
-
-
Dec 2014
-$5.51M(+62.7%)
-
-
Dec 2013
-$3.39M(-17.0%)
-
-
Dec 2012
-$4.08M(+67.0%)
-
-
Dec 2011
-$2.44M(-4.6%)
-
-
Dec 2010
-$2.56M(-2.3%)
-
-
Dec 2009
-$2.62M(+32.6%)
-
-
Dec 2008
-$1.98M(-17.3%)
-
-
Dec 2007
-$2.39M(+247.5%)
-
-
Dec 2006
-$687.70K(<-9900.0%)
-
-
Dec 2005
$3400.00
-
-

FAQ

  • What is Verona Pharma plc annual cash flow from operations?
  • What is the all time high annual CFO for Verona Pharma plc?
  • What is Verona Pharma plc annual CFO year-on-year change?
  • What is Verona Pharma plc quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Verona Pharma plc?
  • What is Verona Pharma plc quarterly CFO year-on-year change?
  • What is Verona Pharma plc TTM cash flow from operations?
  • What is the all time high TTM CFO for Verona Pharma plc?
  • What is Verona Pharma plc TTM CFO year-on-year change?

What is Verona Pharma plc annual cash flow from operations?

The current annual CFO of VRNA is -$122.20M

What is the all time high annual CFO for Verona Pharma plc?

Verona Pharma plc all-time high annual cash flow from operations is $3400.00

What is Verona Pharma plc annual CFO year-on-year change?

Over the past year, VRNA annual cash flow from operations has changed by -$71.98M (-143.33%)

What is Verona Pharma plc quarterly cash flow from operations?

The current quarterly CFO of VRNA is $30.77M

What is the all time high quarterly CFO for Verona Pharma plc?

Verona Pharma plc all-time high quarterly cash flow from operations is $30.77M

What is Verona Pharma plc quarterly CFO year-on-year change?

Over the past year, VRNA quarterly cash flow from operations has changed by +$47.52M (+283.63%)

What is Verona Pharma plc TTM cash flow from operations?

The current TTM CFO of VRNA is -$72.37M

What is the all time high TTM CFO for Verona Pharma plc?

Verona Pharma plc all-time high TTM cash flow from operations is -$4.41M

What is Verona Pharma plc TTM CFO year-on-year change?

Over the past year, VRNA TTM cash flow from operations has changed by -$18.50M (-34.33%)
On this page